Cardiovascular risk factors

Biomarker

2 papers1 finding

  • Human trial1
  • Humans1

Interventions

1

Petrelintide

upin humans1

1 study
  1. Petrelintide improves cardiovascular risk factors in humans.

    “Petrelintide was associated with meaningful improvements in key cardiovascular risk factors (hs-CRP, lipids, BP and waist circumference).”

    Human trialobesity or overweight with complications42 weeksn = 485

    Petrelintide, a Human Amylin Analog for the Treatment of Obesity: Efficacy and Safety from the Phase 2 Trial, ZUPREME 1

    ADA Scientific Sessions 2026 abstract5 Jun 2026

More on Petrelintide

Funding

9 grants since 2023

National Heart, Lung, and Blood InstituteUS$6.6mNational Institute on AgingUS$847.1kNational Cancer InstituteUS$58.9k

Latest

Nov 2025: 54Dec 2025: 37Jan 2026: 13Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 1Jun 2026: 6Jul 2026: 16Aug 2026: 76Sep 2026: 60Oct 2026: 14278 in 12 months
PLOS One

Informal care is linked to less heart disease in older adults

Providing informal care was associated with 15% lower odds of cardiovascular disease, with a prevalence of 8.8% in carers compared to 12.8% in non-carers.Providing informal care was associated with 15% lower odds of cardiovascular disease, with a prevalence of 8.8% in carers compared to 12.8% in non-carers.

Cross-sectional study of 62,881 peoplePopulations
Sleep

Sleep study heart records link to ten-year cardiovascular risk

Across two validation cohorts of over 22,000 patients, an AI score from overnight heart traces yielded hazard ratios of 2.03 and 2.72 for atrial fibrillation.Across two validation cohorts of over 22,000 patients, an AI score from overnight heart traces yielded hazard ratios of 2.03 and 2.72 for atrial fibrillation.

Cohort study of 15,809 peopleBiomarkers
BMJ Open

Heart risk factors stayed high years after the 2008 recession

Blood pressure, blood glucose and inflammation markers in 3,101 adults stayed higher than pre-recession trends predicted, with elevations growing larger over eight to ten…Blood pressure, blood glucose and inflammation markers in 3,101 adults stayed higher than pre-recession trends predicted, with elevations growing larger over eight to ten years.

Cohort study of 3,101 peoplePopulations